1PotKin SG.Aripiprazole,an antipsychotic with a anovel mechanism of action,and risperidone vs placebo in patiens with schizophrenia and with schizoaffective disorder[J].Arch Gen Psychiatry,2003,60(7):681-690
3marder SR,McQuade RD,Stock E,et al.Aripiprazole in the treatment of schizophrenia:safety and tolerability in short -term,placebo-controlled trials[J].Schizophr Res,2003,61(2-3):123-136
3Bowles TM, levin GM. Aripiprazole : A new atypical antipsychotic drug [ J ]. Ann pharmacother, 2003,37 : 687-694.
4Murasaki M. AD-5423 versus haloperidol in the treatment of schizophrenic patients: results of the Japan multicentle, double-blind trial [ J ]. Eur Neuropsychopharmacol, 2002,12 : 5268.
5Gunasekara NS, Spencer CM, Keating GM. Ziprasidone : a review of its use irt schizophrenia and schizoaffective disorder[ J ]. Drugs, 2002,62 :1217-1251.
7Ogasa M,kimura T, Boylan M, et al. SM-13496 in patients with acute exacerbation of schizophrenia: a two-dosc double-blind phase Ⅱ comparison with placebo [ J ]. Schizophr Res, 2003,60 ( Suppl ) : 297.
8Fleischhacker WW, Eerdekens M, Karcher k, et al. Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic[ J ]. J Chin Psychiatry, 2003,64 : 1250-1257.
